'Milestone' reached as world edges closer to vaccine

90% effective

Adam Saville
clock • 1 min read

The RNA vaccine uses an experimental approach that involves injecting part of the virus’ genetic code

The first effective coronavirus vaccine has been developed by American pharmaceutical giant Pfizer and German technology company BioNTech, it is being widely reported in the media. The revolutionary new RNA vaccine technology, which has been tested on 43,500 people in six countries and has no safety concerns so far, is more than 90% effective, trails have shown. Of the dozen or so vaccines in the final phase 3 stage testing, this is the first to show results and the developers plan to apply for emergency approval to use the vaccine by the end of the month. Two doses, three weeks ap...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on PMI

NHS waiting list stagnant in September 2025
PMI

NHS waiting list stagnant in September 2025

7.39m treatments on list

Cameron Roberts
clock 13 November 2025 • 2 min read
Use of insurer-provided health services up by 23%: ABI
PMI

Use of insurer-provided health services up by 23%: ABI

Association calls for IPT freeze

Jaskeet Briah
clock 03 November 2025 • 3 min read
Private healthcare invoices slow in 2025: Healthcode
PMI

Private healthcare invoices slow in 2025: Healthcode

1.6% slowdown in Q3 2025

Cameron Roberts
clock 28 October 2025 • 1 min read